Nidan Wang

Title: Nidan Wang: Innovator in Cancer Treatment

Introduction

Nidan Wang is a prominent inventor based in Beijing, China, known for his significant contributions to the field of biopharmaceuticals. His work primarily focuses on developing innovative treatments for cancer through the use of advanced polypeptides.

Latest Patents

Nidan Wang holds a patent for "Anti-B7S1 polypeptides and their use." This invention relates to anti-B7S1 (B7-H4) polypeptides, including antibodies and their immunoreactive fragments. The patent emphasizes the use of these polypeptides in enhancing the immune system's activation against cancerous cells. The invention also includes genetically engineered immune cells expressing anti-B7S1 CAR, which are utilized for treating various diseases, particularly cancers.

Career Highlights

Throughout his career, Nidan Wang has worked with notable companies in the biopharmaceutical sector, including Suzhou Kanova Biopharmaceutical Co., Ltd. and Beijing Kanova Biopharmaceutical Co., Ltd. His expertise in immunology and cancer treatment has positioned him as a key figure in the development of innovative therapies.

Collaborations

Nidan Wang has collaborated with several professionals in his field, including Li Hui Guo and Tiantian Sun. These collaborations have contributed to the advancement of research and development in cancer treatment.

Conclusion

Nidan Wang's innovative work in the field of biopharmaceuticals, particularly his patent on anti-B7S1 polypeptides, showcases his commitment to improving cancer treatment. His contributions continue to influence the landscape of immunotherapy and cancer research.